Richard S. Levy - 17 Jan 2023 Form 4 Insider Report for MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Role
Director
Signature
/s/ Brian J. Lynch**
Issuer symbol
MDGL
Transactions as of
17 Jan 2023
Net transactions value
-$4,275,841
Form type
4
Filing time
19 Jan 2023, 18:57:34 UTC
Previous filing
05 Jul 2022
Next filing
08 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDGL Common Stock Options Exercise $1,312,344 +12,489 +137% $105.08 21,589 17 Jan 2023 Direct F1
transaction MDGL Common Stock Options Exercise $1,004,500 +10,000 +46% $100.45 31,589 17 Jan 2023 Direct F1
transaction MDGL Common Stock Sale $28,528 -100 -0.32% $285.28 31,489 17 Jan 2023 Direct F1
transaction MDGL Common Stock Sale $114,832 -400 -1.3% $287.08 31,089 17 Jan 2023 Direct F1, F4
transaction MDGL Common Stock Sale $86,673 -300 -0.96% $288.91 30,789 17 Jan 2023 Direct F1, F5
transaction MDGL Common Stock Sale $464,576 -1,600 -5.2% $290.36 29,189 17 Jan 2023 Direct F1, F6
transaction MDGL Common Stock Sale $969,770 -3,325 -11% $291.66 25,864 17 Jan 2023 Direct F1, F7
transaction MDGL Common Stock Sale $1,529,838 -5,227 -20% $292.68 20,637 17 Jan 2023 Direct F1, F8
transaction MDGL Common Stock Sale $1,041,480 -3,548 -17% $293.54 17,089 17 Jan 2023 Direct F1, F9
transaction MDGL Common Stock Sale $1,521,728 -5,164 -30% $294.68 11,925 17 Jan 2023 Direct F1, F10
transaction MDGL Common Stock Sale $686,921 -2,325 -19% $295.45 9,600 17 Jan 2023 Direct F1, F11
transaction MDGL Common Stock Sale $148,340 -500 -5.2% $296.68 9,100 17 Jan 2023 Direct F1, F12

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDGL Stock Option (Right to buy) Options Exercise $0 -12,489 -100% $0.000000* 0 17 Jan 2023 Common Stock 12,489 $105.08 Direct F1, F2
transaction MDGL Stock Option (Right to Buy) Options Exercise $0 -10,000 -100% $0.000000* 0 17 Jan 2023 Common Stock 10,000 $100.45 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. After giving effect to these transactions, the reporting person's Rule 10b5-1 trading plan has been concluded and no more trading will be conducted thereunder.
F2 All shares issued pursuant to the exercise of these options represent 12,489 shares underlying an option award of 12,489 shares. All exercised options vested June 17, 2022.
F3 All shares issued pursuant to the exercise of these options represent 10,000 shares underlying an option award of 10,000 shares. All exercised options vested June 27, 2020.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $286.99 to $287.16, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $288.73 to $289.01, inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $289.80 to $290.79, inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $291.08 to $292.07, inclusive.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $292.11 to $293.09, inclusive.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $293.12 to $294.11, inclusive.
F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $294.17 to $295.16, inclusive.
F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $295.26 to $296.15, inclusive.
F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $296.43 to $296.77, inclusive.

Remarks:

** As attorney-in-fact for Reporting Person